DIALYSIS · CCN 132532

DaVita Syringa Home Training ID

BOISE, ID 83706

DialysisProfitDaVita
$2.9M
TOTAL REVENUE
15.1%
OPERATING MARGIN
N/A
STAR RATING
9
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.9M
Total costs
$2.5M
Operating income (rev − costs)
$446K
Operating margin
15.1%
Total charges
$3.2M
Total treatments
6,314
Dialysis stations
—

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

9 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.0719—
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.1927—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
107.455—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
24.4219—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
14.550—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
19.228—
Standardized ED Visits Ratio
DFC_SEDR
0.8122—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
18.320—